In chronic lymphocytic leukemia, cancer cells constitutively express A2AR, and autonomous adenosine production with their own CD39/CD73 can result in A2AR-dependent prevention of drug-induced apoptosis (78). This evidence concerns the gene ADORA2A and B-cell chronic lymphocytic leukemia.